PeopleBio, Inc. (KOSDAQ:304840)

South Korea · Delayed Price · Currency is KRW

759.00

-41.00 (-5.13%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Biotechnology	3.73B	4.45B	4.44B	577.08M	507.85M
Biotechnology Growth	-16.20%	0.18%	670.22%	13.63%	-
Total	3.73B	4.45B	4.44B	577.08M	507.85M
Total Growth	-16.20%	0.18%	670.22%	13.63%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Korea	3.45B	4.43B	4.42B	537.64M	507.85M
Korea Growth	-22.11%	0.37%	721.30%	5.87%	-
Asia	53.95M	18.37M	29.17M	39.44M	-
Asia Growth	193.70%	-37.03%	-26.05%	-	-
Europe	225.38M	2.31M	-	-	-
Europe Growth	9652.27%	-	-	-	-
Total	3.73B	4.45B	4.44B	577.08M	507.85M
Total Growth	-16.20%	0.18%	670.22%	13.63%	-

Source: S&P Global Market Intelligence.